Professor Andrew Wardley

Consultant Medical Oncologist for Breast Cancer and Medical Director of the NIHR Manchester Clinical Research Facility at The Christie, Manchester, UK

Professor Andrew Wardley

Consultant Medical Oncologist for Breast Cancer and Medical Director of the NIHR Manchester Clinical Research Facility at The Christie, Manchester, UK
Back

Biography

Professor Andrew Wardley is a Consultant Medical Oncologist for breast cancer and Medical Director of the NIHR Manchester Clinical Research Facility at The Christie. Professor Wardley is also the Director for Systemic Anti-Cancer Therapy in Greater Manchester. He leads The Christie/Greater Manchester strategy to increase patient access to access to systemic anti-cancer therapy clinical trials across the conurbation.
Professor Wardley is Lead of the Clinical Research Group within the Manchester Breast Centre, of which he was a co-founder. His research interests include introducing new treatments in advanced breast cancer and translating clinical research into clinical practice. Professor Wardley has also been involved in major developments in HER2-positive breast cancer, including adjuvant trastuzumab (Herceptin) and pertuzumab (PERJETA) clinical development.

Sessions by Professor Andrew Wardley

The New MDMT

09:35-10:55
Hall 1